Itay&biond develops a drug discovery platform to establish the next generation of treatments for Autism Spectrum Disorders and other Psychiatric and Neurological Dysfunctions.
These compounds will be going through a unique and patented estimation of their clinical efficacy using the novel technology that underlies our drug discovery platform. The most promising compounds will go on for pre-clinical study.
Our business opportunities include licensing, co-development, and sells of drugs developed up to pre-IND.
Promising preliminary results of the RNA-based molecule for treating sub-population of Autism spectrum disorders
RNA-based molecule for treating sub-population of Autism spectrum disorders
Novel scalable non-invasive sample collection device
200 samples of ASD patients
Growing hundred of ASD patients brain organoids
Scalable drug screening and discovery platform